D S Feingold, R F Wagner. Show Affiliations »
Abstract
Mesh： See more » Anti-Bacterial Agents/therapeutic useAnti-Infective Agents, Local/therapeutic useCephalosporins/therapeutic useClindamycin/therapeutic useDrug Combinations/therapeutic useErythromycin/therapeutic useHumansMethicillin/therapeutic useMetronidazole/therapeutic useNalidixic Acid/analogs & derivativesPenicillin ResistancePenicillins/therapeutic useRifampin/therapeutic useSkin Diseases, Infectious/drug therapyStaphylococcal Infections/drug therapyStaphylococcus aureus/drug effectsSulfamethoxazole/therapeutic useTetracycline/therapeutic useTrimethoprim/therapeutic useTrimethoprim, Sulfamethoxazole Drug CombinationVancomycin/therapeutic use
Substances： See more » Anti-Bacterial AgentsAnti-Infective Agents, LocalCephalosporinsDrug CombinationsPenicillinsMetronidazoleNalidixic AcidClindamycinErythromycinVancomycinTrimethoprim, Sulfamethoxazole Drug CombinationTrimethoprimTetracyclineSulfamethoxazoleMethicillinRifampin
Year: 1986 PMID： 3514701 DOI： 10.1016/s0190-9622(86)80441-8
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527